Obesity News

Adults with overweight or obesity who received metformin shortly after a COVID-19 diagnosis had a lower risk for developing long COVID than those receiving placebo, according to study data.

Leading experts from cardiorenal metabolic specialties will present the latest research with clinical implications for diabetes, CVD and kidney disease, with a new format this year designed to drive multispecialty discussions.

Women exposed to higher concentrations of per- and polyfluoroalkyl substances during pregnancy have children with higher BMI z scores and greater risks for overweight or obesity at age 2 to 5 years, according to study data.

Youth in the United States have increasingly undergone metabolic and bariatric surgery to lose weight in recent years, according to a study published in JAMA Pediatrics.

This month marks 10 years since the AMA recognized obesity as a complex disease.

Adults with obesity who used semaglutide for weight loss reduced their 10-year risk for atherosclerotic cardiovascular disease, according to findings presented at the European Congress on Obesity.

Adults with overweight or obesity receiving semaglutide lost 13.4% of their body weight at 1 year, according to findings from a real-world study presented at the European Congress on Obesity.

The FDA is advising people using semaglutide to avoid some compounded formulations due to the use of ingredients that may cause adverse events, according to a safety notice.

Metabolically healthy and unhealthy obesity appeared associated with increased risk for various obesity-associated cancer types, according to study results presented at European Congress on Obesity.

Health care professionals must collect more detailed and accurate demographic data and identify factors contributing to health disparities in pediatric endocrinology and gender care, according to a scientific statement.